-
Tx-LLM: A Large Language Model for Therapeutics
Authors:
Juan Manuel Zambrano Chaves,
Eric Wang,
Tao Tu,
Eeshit Dhaval Vaishnav,
Byron Lee,
S. Sara Mahdavi,
Christopher Semturs,
David Fleet,
Vivek Natarajan,
Shekoofeh Azizi
Abstract:
Developing therapeutics is a lengthy and expensive process that requires the satisfaction of many different criteria, and AI models capable of expediting the process would be invaluable. However, the majority of current AI approaches address only a narrowly defined set of tasks, often circumscribed within a particular domain. To bridge this gap, we introduce Tx-LLM, a generalist large language mod…
▽ More
Developing therapeutics is a lengthy and expensive process that requires the satisfaction of many different criteria, and AI models capable of expediting the process would be invaluable. However, the majority of current AI approaches address only a narrowly defined set of tasks, often circumscribed within a particular domain. To bridge this gap, we introduce Tx-LLM, a generalist large language model (LLM) fine-tuned from PaLM-2 which encodes knowledge about diverse therapeutic modalities. Tx-LLM is trained using a collection of 709 datasets that target 66 tasks spanning various stages of the drug discovery pipeline. Using a single set of weights, Tx-LLM simultaneously processes a wide variety of chemical or biological entities(small molecules, proteins, nucleic acids, cell lines, diseases) interleaved with free-text, allowing it to predict a broad range of associated properties, achieving competitive with state-of-the-art (SOTA) performance on 43 out of 66 tasks and exceeding SOTA on 22. Among these, Tx-LLM is particularly powerful and exceeds best-in-class performance on average for tasks combining molecular SMILES representations with text such as cell line names or disease names, likely due to context learned during pretraining. We observe evidence of positive transfer between tasks with diverse drug types (e.g.,tasks involving small molecules and tasks involving proteins), and we study the impact of model size, domain finetuning, and prompting strategies on performance. We believe Tx-LLM represents an important step towards LLMs encoding biochemical knowledge and could have a future role as an end-to-end tool across the drug discovery development pipeline.
△ Less
Submitted 10 June, 2024;
originally announced June 2024.
-
Advancing Multimodal Medical Capabilities of Gemini
Authors:
Lin Yang,
Shawn Xu,
Andrew Sellergren,
Timo Kohlberger,
Yuchen Zhou,
Ira Ktena,
Atilla Kiraly,
Faruk Ahmed,
Farhad Hormozdiari,
Tiam Jaroensri,
Eric Wang,
Ellery Wulczyn,
Fayaz Jamil,
Theo Guidroz,
Chuck Lau,
Siyuan Qiao,
Yun Liu,
Akshay Goel,
Kendall Park,
Arnav Agharwal,
Nick George,
Yang Wang,
Ryutaro Tanno,
David G. T. Barrett,
Wei-Hung Weng
, et al. (22 additional authors not shown)
Abstract:
Many clinical tasks require an understanding of specialized data, such as medical images and genomics, which is not typically found in general-purpose large multimodal models. Building upon Gemini's multimodal models, we develop several models within the new Med-Gemini family that inherit core capabilities of Gemini and are optimized for medical use via fine-tuning with 2D and 3D radiology, histop…
▽ More
Many clinical tasks require an understanding of specialized data, such as medical images and genomics, which is not typically found in general-purpose large multimodal models. Building upon Gemini's multimodal models, we develop several models within the new Med-Gemini family that inherit core capabilities of Gemini and are optimized for medical use via fine-tuning with 2D and 3D radiology, histopathology, ophthalmology, dermatology and genomic data. Med-Gemini-2D sets a new standard for AI-based chest X-ray (CXR) report generation based on expert evaluation, exceeding previous best results across two separate datasets by an absolute margin of 1% and 12%, where 57% and 96% of AI reports on normal cases, and 43% and 65% on abnormal cases, are evaluated as "equivalent or better" than the original radiologists' reports. We demonstrate the first ever large multimodal model-based report generation for 3D computed tomography (CT) volumes using Med-Gemini-3D, with 53% of AI reports considered clinically acceptable, although additional research is needed to meet expert radiologist reporting quality. Beyond report generation, Med-Gemini-2D surpasses the previous best performance in CXR visual question answering (VQA) and performs well in CXR classification and radiology VQA, exceeding SoTA or baselines on 17 of 20 tasks. In histopathology, ophthalmology, and dermatology image classification, Med-Gemini-2D surpasses baselines across 18 out of 20 tasks and approaches task-specific model performance. Beyond imaging, Med-Gemini-Polygenic outperforms the standard linear polygenic risk score-based approach for disease risk prediction and generalizes to genetically correlated diseases for which it has never been trained. Although further development and evaluation are necessary in the safety-critical medical domain, our results highlight the potential of Med-Gemini across a wide range of medical tasks.
△ Less
Submitted 6 May, 2024;
originally announced May 2024.
-
Capabilities of Gemini Models in Medicine
Authors:
Khaled Saab,
Tao Tu,
Wei-Hung Weng,
Ryutaro Tanno,
David Stutz,
Ellery Wulczyn,
Fan Zhang,
Tim Strother,
Chunjong Park,
Elahe Vedadi,
Juanma Zambrano Chaves,
Szu-Yeu Hu,
Mike Schaekermann,
Aishwarya Kamath,
Yong Cheng,
David G. T. Barrett,
Cathy Cheung,
Basil Mustafa,
Anil Palepu,
Daniel McDuff,
Le Hou,
Tomer Golany,
Luyang Liu,
Jean-baptiste Alayrac,
Neil Houlsby
, et al. (42 additional authors not shown)
Abstract:
Excellence in a wide variety of medical applications poses considerable challenges for AI, requiring advanced reasoning, access to up-to-date medical knowledge and understanding of complex multimodal data. Gemini models, with strong general capabilities in multimodal and long-context reasoning, offer exciting possibilities in medicine. Building on these core strengths of Gemini, we introduce Med-G…
▽ More
Excellence in a wide variety of medical applications poses considerable challenges for AI, requiring advanced reasoning, access to up-to-date medical knowledge and understanding of complex multimodal data. Gemini models, with strong general capabilities in multimodal and long-context reasoning, offer exciting possibilities in medicine. Building on these core strengths of Gemini, we introduce Med-Gemini, a family of highly capable multimodal models that are specialized in medicine with the ability to seamlessly use web search, and that can be efficiently tailored to novel modalities using custom encoders. We evaluate Med-Gemini on 14 medical benchmarks, establishing new state-of-the-art (SoTA) performance on 10 of them, and surpass the GPT-4 model family on every benchmark where a direct comparison is viable, often by a wide margin. On the popular MedQA (USMLE) benchmark, our best-performing Med-Gemini model achieves SoTA performance of 91.1% accuracy, using a novel uncertainty-guided search strategy. On 7 multimodal benchmarks including NEJM Image Challenges and MMMU (health & medicine), Med-Gemini improves over GPT-4V by an average relative margin of 44.5%. We demonstrate the effectiveness of Med-Gemini's long-context capabilities through SoTA performance on a needle-in-a-haystack retrieval task from long de-identified health records and medical video question answering, surpassing prior bespoke methods using only in-context learning. Finally, Med-Gemini's performance suggests real-world utility by surpassing human experts on tasks such as medical text summarization, alongside demonstrations of promising potential for multimodal medical dialogue, medical research and education. Taken together, our results offer compelling evidence for Med-Gemini's potential, although further rigorous evaluation will be crucial before real-world deployment in this safety-critical domain.
△ Less
Submitted 1 May, 2024; v1 submitted 29 April, 2024;
originally announced April 2024.
-
Towards Conversational Diagnostic AI
Authors:
Tao Tu,
Anil Palepu,
Mike Schaekermann,
Khaled Saab,
Jan Freyberg,
Ryutaro Tanno,
Amy Wang,
Brenna Li,
Mohamed Amin,
Nenad Tomasev,
Shekoofeh Azizi,
Karan Singhal,
Yong Cheng,
Le Hou,
Albert Webson,
Kavita Kulkarni,
S Sara Mahdavi,
Christopher Semturs,
Juraj Gottweis,
Joelle Barral,
Katherine Chou,
Greg S Corrado,
Yossi Matias,
Alan Karthikesalingam,
Vivek Natarajan
Abstract:
At the heart of medicine lies the physician-patient dialogue, where skillful history-taking paves the way for accurate diagnosis, effective management, and enduring trust. Artificial Intelligence (AI) systems capable of diagnostic dialogue could increase accessibility, consistency, and quality of care. However, approximating clinicians' expertise is an outstanding grand challenge. Here, we introdu…
▽ More
At the heart of medicine lies the physician-patient dialogue, where skillful history-taking paves the way for accurate diagnosis, effective management, and enduring trust. Artificial Intelligence (AI) systems capable of diagnostic dialogue could increase accessibility, consistency, and quality of care. However, approximating clinicians' expertise is an outstanding grand challenge. Here, we introduce AMIE (Articulate Medical Intelligence Explorer), a Large Language Model (LLM) based AI system optimized for diagnostic dialogue.
AMIE uses a novel self-play based simulated environment with automated feedback mechanisms for scaling learning across diverse disease conditions, specialties, and contexts. We designed a framework for evaluating clinically-meaningful axes of performance including history-taking, diagnostic accuracy, management reasoning, communication skills, and empathy. We compared AMIE's performance to that of primary care physicians (PCPs) in a randomized, double-blind crossover study of text-based consultations with validated patient actors in the style of an Objective Structured Clinical Examination (OSCE). The study included 149 case scenarios from clinical providers in Canada, the UK, and India, 20 PCPs for comparison with AMIE, and evaluations by specialist physicians and patient actors. AMIE demonstrated greater diagnostic accuracy and superior performance on 28 of 32 axes according to specialist physicians and 24 of 26 axes according to patient actors. Our research has several limitations and should be interpreted with appropriate caution. Clinicians were limited to unfamiliar synchronous text-chat which permits large-scale LLM-patient interactions but is not representative of usual clinical practice. While further research is required before AMIE could be translated to real-world settings, the results represent a milestone towards conversational diagnostic AI.
△ Less
Submitted 10 January, 2024;
originally announced January 2024.
-
Towards Accurate Differential Diagnosis with Large Language Models
Authors:
Daniel McDuff,
Mike Schaekermann,
Tao Tu,
Anil Palepu,
Amy Wang,
Jake Garrison,
Karan Singhal,
Yash Sharma,
Shekoofeh Azizi,
Kavita Kulkarni,
Le Hou,
Yong Cheng,
Yun Liu,
S Sara Mahdavi,
Sushant Prakash,
Anupam Pathak,
Christopher Semturs,
Shwetak Patel,
Dale R Webster,
Ewa Dominowska,
Juraj Gottweis,
Joelle Barral,
Katherine Chou,
Greg S Corrado,
Yossi Matias
, et al. (3 additional authors not shown)
Abstract:
An accurate differential diagnosis (DDx) is a cornerstone of medical care, often reached through an iterative process of interpretation that combines clinical history, physical examination, investigations and procedures. Interactive interfaces powered by Large Language Models (LLMs) present new opportunities to both assist and automate aspects of this process. In this study, we introduce an LLM op…
▽ More
An accurate differential diagnosis (DDx) is a cornerstone of medical care, often reached through an iterative process of interpretation that combines clinical history, physical examination, investigations and procedures. Interactive interfaces powered by Large Language Models (LLMs) present new opportunities to both assist and automate aspects of this process. In this study, we introduce an LLM optimized for diagnostic reasoning, and evaluate its ability to generate a DDx alone or as an aid to clinicians. 20 clinicians evaluated 302 challenging, real-world medical cases sourced from the New England Journal of Medicine (NEJM) case reports. Each case report was read by two clinicians, who were randomized to one of two assistive conditions: either assistance from search engines and standard medical resources, or LLM assistance in addition to these tools. All clinicians provided a baseline, unassisted DDx prior to using the respective assistive tools. Our LLM for DDx exhibited standalone performance that exceeded that of unassisted clinicians (top-10 accuracy 59.1% vs 33.6%, [p = 0.04]). Comparing the two assisted study arms, the DDx quality score was higher for clinicians assisted by our LLM (top-10 accuracy 51.7%) compared to clinicians without its assistance (36.1%) (McNemar's Test: 45.7, p < 0.01) and clinicians with search (44.4%) (4.75, p = 0.03). Further, clinicians assisted by our LLM arrived at more comprehensive differential lists than those without its assistance. Our study suggests that our LLM for DDx has potential to improve clinicians' diagnostic reasoning and accuracy in challenging cases, meriting further real-world evaluation for its ability to empower physicians and widen patients' access to specialist-level expertise.
△ Less
Submitted 30 November, 2023;
originally announced December 2023.
-
Towards Generalist Biomedical AI
Authors:
Tao Tu,
Shekoofeh Azizi,
Danny Driess,
Mike Schaekermann,
Mohamed Amin,
Pi-Chuan Chang,
Andrew Carroll,
Chuck Lau,
Ryutaro Tanno,
Ira Ktena,
Basil Mustafa,
Aakanksha Chowdhery,
Yun Liu,
Simon Kornblith,
David Fleet,
Philip Mansfield,
Sushant Prakash,
Renee Wong,
Sunny Virmani,
Christopher Semturs,
S Sara Mahdavi,
Bradley Green,
Ewa Dominowska,
Blaise Aguera y Arcas,
Joelle Barral
, et al. (7 additional authors not shown)
Abstract:
Medicine is inherently multimodal, with rich data modalities spanning text, imaging, genomics, and more. Generalist biomedical artificial intelligence (AI) systems that flexibly encode, integrate, and interpret this data at scale can potentially enable impactful applications ranging from scientific discovery to care delivery. To enable the development of these models, we first curate MultiMedBench…
▽ More
Medicine is inherently multimodal, with rich data modalities spanning text, imaging, genomics, and more. Generalist biomedical artificial intelligence (AI) systems that flexibly encode, integrate, and interpret this data at scale can potentially enable impactful applications ranging from scientific discovery to care delivery. To enable the development of these models, we first curate MultiMedBench, a new multimodal biomedical benchmark. MultiMedBench encompasses 14 diverse tasks such as medical question answering, mammography and dermatology image interpretation, radiology report generation and summarization, and genomic variant calling. We then introduce Med-PaLM Multimodal (Med-PaLM M), our proof of concept for a generalist biomedical AI system. Med-PaLM M is a large multimodal generative model that flexibly encodes and interprets biomedical data including clinical language, imaging, and genomics with the same set of model weights. Med-PaLM M reaches performance competitive with or exceeding the state of the art on all MultiMedBench tasks, often surpassing specialist models by a wide margin. We also report examples of zero-shot generalization to novel medical concepts and tasks, positive transfer learning across tasks, and emergent zero-shot medical reasoning. To further probe the capabilities and limitations of Med-PaLM M, we conduct a radiologist evaluation of model-generated (and human) chest X-ray reports and observe encouraging performance across model scales. In a side-by-side ranking on 246 retrospective chest X-rays, clinicians express a pairwise preference for Med-PaLM M reports over those produced by radiologists in up to 40.50% of cases, suggesting potential clinical utility. While considerable work is needed to validate these models in real-world use cases, our results represent a milestone towards the development of generalist biomedical AI systems.
△ Less
Submitted 26 July, 2023;
originally announced July 2023.
-
Towards Expert-Level Medical Question Answering with Large Language Models
Authors:
Karan Singhal,
Tao Tu,
Juraj Gottweis,
Rory Sayres,
Ellery Wulczyn,
Le Hou,
Kevin Clark,
Stephen Pfohl,
Heather Cole-Lewis,
Darlene Neal,
Mike Schaekermann,
Amy Wang,
Mohamed Amin,
Sami Lachgar,
Philip Mansfield,
Sushant Prakash,
Bradley Green,
Ewa Dominowska,
Blaise Aguera y Arcas,
Nenad Tomasev,
Yun Liu,
Renee Wong,
Christopher Semturs,
S. Sara Mahdavi,
Joelle Barral
, et al. (6 additional authors not shown)
Abstract:
Recent artificial intelligence (AI) systems have reached milestones in "grand challenges" ranging from Go to protein-folding. The capability to retrieve medical knowledge, reason over it, and answer medical questions comparably to physicians has long been viewed as one such grand challenge.
Large language models (LLMs) have catalyzed significant progress in medical question answering; Med-PaLM w…
▽ More
Recent artificial intelligence (AI) systems have reached milestones in "grand challenges" ranging from Go to protein-folding. The capability to retrieve medical knowledge, reason over it, and answer medical questions comparably to physicians has long been viewed as one such grand challenge.
Large language models (LLMs) have catalyzed significant progress in medical question answering; Med-PaLM was the first model to exceed a "passing" score in US Medical Licensing Examination (USMLE) style questions with a score of 67.2% on the MedQA dataset. However, this and other prior work suggested significant room for improvement, especially when models' answers were compared to clinicians' answers. Here we present Med-PaLM 2, which bridges these gaps by leveraging a combination of base LLM improvements (PaLM 2), medical domain finetuning, and prompting strategies including a novel ensemble refinement approach.
Med-PaLM 2 scored up to 86.5% on the MedQA dataset, improving upon Med-PaLM by over 19% and setting a new state-of-the-art. We also observed performance approaching or exceeding state-of-the-art across MedMCQA, PubMedQA, and MMLU clinical topics datasets.
We performed detailed human evaluations on long-form questions along multiple axes relevant to clinical applications. In pairwise comparative ranking of 1066 consumer medical questions, physicians preferred Med-PaLM 2 answers to those produced by physicians on eight of nine axes pertaining to clinical utility (p < 0.001). We also observed significant improvements compared to Med-PaLM on every evaluation axis (p < 0.001) on newly introduced datasets of 240 long-form "adversarial" questions to probe LLM limitations.
While further studies are necessary to validate the efficacy of these models in real-world settings, these results highlight rapid progress towards physician-level performance in medical question answering.
△ Less
Submitted 16 May, 2023;
originally announced May 2023.
-
Large Language Models Encode Clinical Knowledge
Authors:
Karan Singhal,
Shekoofeh Azizi,
Tao Tu,
S. Sara Mahdavi,
Jason Wei,
Hyung Won Chung,
Nathan Scales,
Ajay Tanwani,
Heather Cole-Lewis,
Stephen Pfohl,
Perry Payne,
Martin Seneviratne,
Paul Gamble,
Chris Kelly,
Nathaneal Scharli,
Aakanksha Chowdhery,
Philip Mansfield,
Blaise Aguera y Arcas,
Dale Webster,
Greg S. Corrado,
Yossi Matias,
Katherine Chou,
Juraj Gottweis,
Nenad Tomasev,
Yun Liu
, et al. (5 additional authors not shown)
Abstract:
Large language models (LLMs) have demonstrated impressive capabilities in natural language understanding and generation, but the quality bar for medical and clinical applications is high. Today, attempts to assess models' clinical knowledge typically rely on automated evaluations on limited benchmarks. There is no standard to evaluate model predictions and reasoning across a breadth of tasks. To a…
▽ More
Large language models (LLMs) have demonstrated impressive capabilities in natural language understanding and generation, but the quality bar for medical and clinical applications is high. Today, attempts to assess models' clinical knowledge typically rely on automated evaluations on limited benchmarks. There is no standard to evaluate model predictions and reasoning across a breadth of tasks. To address this, we present MultiMedQA, a benchmark combining six existing open question answering datasets spanning professional medical exams, research, and consumer queries; and HealthSearchQA, a new free-response dataset of medical questions searched online. We propose a framework for human evaluation of model answers along multiple axes including factuality, precision, possible harm, and bias. In addition, we evaluate PaLM (a 540-billion parameter LLM) and its instruction-tuned variant, Flan-PaLM, on MultiMedQA. Using a combination of prompting strategies, Flan-PaLM achieves state-of-the-art accuracy on every MultiMedQA multiple-choice dataset (MedQA, MedMCQA, PubMedQA, MMLU clinical topics), including 67.6% accuracy on MedQA (US Medical License Exam questions), surpassing prior state-of-the-art by over 17%. However, human evaluation reveals key gaps in Flan-PaLM responses. To resolve this we introduce instruction prompt tuning, a parameter-efficient approach for aligning LLMs to new domains using a few exemplars. The resulting model, Med-PaLM, performs encouragingly, but remains inferior to clinicians. We show that comprehension, recall of knowledge, and medical reasoning improve with model scale and instruction prompt tuning, suggesting the potential utility of LLMs in medicine. Our human evaluations reveal important limitations of today's models, reinforcing the importance of both evaluation frameworks and method development in creating safe, helpful LLM models for clinical applications.
△ Less
Submitted 26 December, 2022;
originally announced December 2022.
-
Photorealistic Text-to-Image Diffusion Models with Deep Language Understanding
Authors:
Chitwan Saharia,
William Chan,
Saurabh Saxena,
Lala Li,
Jay Whang,
Emily Denton,
Seyed Kamyar Seyed Ghasemipour,
Burcu Karagol Ayan,
S. Sara Mahdavi,
Rapha Gontijo Lopes,
Tim Salimans,
Jonathan Ho,
David J Fleet,
Mohammad Norouzi
Abstract:
We present Imagen, a text-to-image diffusion model with an unprecedented degree of photorealism and a deep level of language understanding. Imagen builds on the power of large transformer language models in understanding text and hinges on the strength of diffusion models in high-fidelity image generation. Our key discovery is that generic large language models (e.g. T5), pretrained on text-only c…
▽ More
We present Imagen, a text-to-image diffusion model with an unprecedented degree of photorealism and a deep level of language understanding. Imagen builds on the power of large transformer language models in understanding text and hinges on the strength of diffusion models in high-fidelity image generation. Our key discovery is that generic large language models (e.g. T5), pretrained on text-only corpora, are surprisingly effective at encoding text for image synthesis: increasing the size of the language model in Imagen boosts both sample fidelity and image-text alignment much more than increasing the size of the image diffusion model. Imagen achieves a new state-of-the-art FID score of 7.27 on the COCO dataset, without ever training on COCO, and human raters find Imagen samples to be on par with the COCO data itself in image-text alignment. To assess text-to-image models in greater depth, we introduce DrawBench, a comprehensive and challenging benchmark for text-to-image models. With DrawBench, we compare Imagen with recent methods including VQ-GAN+CLIP, Latent Diffusion Models, and DALL-E 2, and find that human raters prefer Imagen over other models in side-by-side comparisons, both in terms of sample quality and image-text alignment. See https://imagen.research.google/ for an overview of the results.
△ Less
Submitted 23 May, 2022;
originally announced May 2022.
-
Robust and Efficient Medical Imaging with Self-Supervision
Authors:
Shekoofeh Azizi,
Laura Culp,
Jan Freyberg,
Basil Mustafa,
Sebastien Baur,
Simon Kornblith,
Ting Chen,
Patricia MacWilliams,
S. Sara Mahdavi,
Ellery Wulczyn,
Boris Babenko,
Megan Wilson,
Aaron Loh,
Po-Hsuan Cameron Chen,
Yuan Liu,
Pinal Bavishi,
Scott Mayer McKinney,
Jim Winkens,
Abhijit Guha Roy,
Zach Beaver,
Fiona Ryan,
Justin Krogue,
Mozziyar Etemadi,
Umesh Telang,
Yun Liu
, et al. (9 additional authors not shown)
Abstract:
Recent progress in Medical Artificial Intelligence (AI) has delivered systems that can reach clinical expert level performance. However, such systems tend to demonstrate sub-optimal "out-of-distribution" performance when evaluated in clinical settings different from the training environment. A common mitigation strategy is to develop separate systems for each clinical setting using site-specific d…
▽ More
Recent progress in Medical Artificial Intelligence (AI) has delivered systems that can reach clinical expert level performance. However, such systems tend to demonstrate sub-optimal "out-of-distribution" performance when evaluated in clinical settings different from the training environment. A common mitigation strategy is to develop separate systems for each clinical setting using site-specific data [1]. However, this quickly becomes impractical as medical data is time-consuming to acquire and expensive to annotate [2]. Thus, the problem of "data-efficient generalization" presents an ongoing difficulty for Medical AI development. Although progress in representation learning shows promise, their benefits have not been rigorously studied, specifically for out-of-distribution settings. To meet these challenges, we present REMEDIS, a unified representation learning strategy to improve robustness and data-efficiency of medical imaging AI. REMEDIS uses a generic combination of large-scale supervised transfer learning with self-supervised learning and requires little task-specific customization. We study a diverse range of medical imaging tasks and simulate three realistic application scenarios using retrospective data. REMEDIS exhibits significantly improved in-distribution performance with up to 11.5% relative improvement in diagnostic accuracy over a strong supervised baseline. More importantly, our strategy leads to strong data-efficient generalization of medical imaging AI, matching strong supervised baselines using between 1% to 33% of retraining data across tasks. These results suggest that REMEDIS can significantly accelerate the life-cycle of medical imaging AI development thereby presenting an important step forward for medical imaging AI to deliver broad impact.
△ Less
Submitted 3 July, 2022; v1 submitted 19 May, 2022;
originally announced May 2022.
-
Rapid treatment planning for low-dose-rate prostate brachytherapy with TP-GAN
Authors:
Tajwar Abrar Aleef,
Ingrid T. Spadinger,
Michael D. Peacock,
Septimiu E. Salcudean,
S. Sara Mahdavi
Abstract:
Treatment planning in low-dose-rate prostate brachytherapy (LDR-PB) aims to produce arrangement of implantable radioactive seeds that deliver a minimum prescribed dose to the prostate whilst minimizing toxicity to healthy tissues. There can be multiple seed arrangements that satisfy this dosimetric criterion, not all deemed 'acceptable' for implant from a physician's perspective. This leads to pla…
▽ More
Treatment planning in low-dose-rate prostate brachytherapy (LDR-PB) aims to produce arrangement of implantable radioactive seeds that deliver a minimum prescribed dose to the prostate whilst minimizing toxicity to healthy tissues. There can be multiple seed arrangements that satisfy this dosimetric criterion, not all deemed 'acceptable' for implant from a physician's perspective. This leads to plans that are subjective to the physician's/centre's preference, planning style, and expertise. We propose a method that aims to reduce this variability by training a model to learn from a large pool of successful retrospective LDR-PB data (961 patients) and create consistent plans that mimic the high-quality manual plans. Our model is based on conditional generative adversarial networks that use a novel loss function for penalizing the model on spatial constraints of the seeds. An optional optimizer based on a simulated annealing (SA) algorithm can be used to further fine-tune the plans if necessary (determined by the treating physician). Performance analysis was conducted on 150 test cases demonstrating comparable results to that of the manual prehistorical plans. On average, the clinical target volume covering 100% of the prescribed dose was 98.9% for our method compared to 99.4% for manual plans. Moreover, using our model, the planning time was significantly reduced to an average of 2.5 mins/plan with SA, and less than 3 seconds without SA. Compared to this, manual planning at our centre takes around 20 mins/plan.
△ Less
Submitted 17 March, 2021;
originally announced March 2021.
-
Clearing an Orthogonal Polygon Using Sliding Robots
Authors:
Mohammad Ghodsi,
Salma Sadat Mahdavi,
Ali Narenji Sheshkalani
Abstract:
In a multi-robot system, a number of autonomous robots would sense, communicate, and decide to move within a given domain to achieve a common goal. In this paper, we consider a new variant of the pursuit-evasion problem in which the robots (pursuers) each move back and forth along an orthogonal line segment inside a simple orthogonal polygon $P$. A point $p$ can be covered by a sliding robot that…
▽ More
In a multi-robot system, a number of autonomous robots would sense, communicate, and decide to move within a given domain to achieve a common goal. In this paper, we consider a new variant of the pursuit-evasion problem in which the robots (pursuers) each move back and forth along an orthogonal line segment inside a simple orthogonal polygon $P$. A point $p$ can be covered by a sliding robot that moves along a line segment s, if there exists a point $q\in s$ such that $\overline{pq}$ is a line segment perpendicular to $s$. In the pursuit-evasion problem, a polygonal region is given and a robot called a pursuer tries to find some mobile targets called evaders. The goal of this problem is to design a motion strategy for the pursuer such that it can detect all the evaders. We assume that $P$ includes unpredictable, moving evaders that have unbounded speed. We propose a motion-planning algorithm for a group of sliding robots, assuming that they move along the pre-located line segments with a constant speed to detect all the evaders with unbounded speed.
△ Less
Submitted 15 August, 2016; v1 submitted 11 July, 2016;
originally announced July 2016.